- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 52 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
CLR.4: 16 residues within 4Å:- Chain A: Y.922, S.926, L.966, I.969, F.970, V.973
- Chain B: W.1070, L.1071, F.1074, L.1075, V.1078
- Ligands: POV.1, POV.5, POV.6, POV.7, POV.8
11 PLIP interactions:8 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:L.966, A:I.969, A:F.970, A:F.970, A:F.970, B:L.1071, B:F.1074, B:L.1075
- Hydrogen bonds: A:Y.922, A:S.926, A:S.926
CLR.24: 16 residues within 4Å:- Chain B: Y.922, S.926, L.966, I.969, F.970, V.973
- Chain C: W.1070, L.1071, F.1074, L.1075, V.1078
- Ligands: POV.21, POV.25, POV.26, POV.27, POV.36
13 PLIP interactions:8 interactions with chain B, 5 interactions with chain C- Hydrophobic interactions: B:L.966, B:I.969, B:F.970, B:F.970, B:F.970, C:W.1070, C:W.1070, C:L.1071, C:F.1074, C:L.1075
- Hydrogen bonds: B:Y.922, B:S.926, B:S.926
CLR.40: 16 residues within 4Å:- Chain C: Y.922, S.926, L.966, I.969, F.970, V.973
- Chain D: W.1070, L.1071, F.1074, L.1075, V.1078
- Ligands: POV.37, POV.41, POV.42, POV.43, POV.53
13 PLIP interactions:8 interactions with chain C, 5 interactions with chain D- Hydrophobic interactions: C:L.966, C:I.969, C:F.970, C:F.970, C:F.970, D:W.1070, D:W.1070, D:L.1071, D:F.1074, D:L.1075
- Hydrogen bonds: C:Y.922, C:S.926, C:S.926
CLR.57: 16 residues within 4Å:- Chain A: W.1070, L.1071, F.1074, L.1075, V.1078
- Chain D: Y.922, S.926, L.966, I.969, F.970, V.973
- Ligands: POV.18, POV.19, POV.54, POV.58, POV.59
13 PLIP interactions:5 interactions with chain A, 8 interactions with chain D- Hydrophobic interactions: A:W.1070, A:W.1070, A:L.1071, A:F.1074, A:L.1075, D:L.966, D:I.969, D:F.970, D:F.970, D:F.970
- Hydrogen bonds: D:Y.922, D:S.926, D:S.926
- 4 x DU0: 2-[2-[(1~{S},2~{S},4~{S},5'~{R},6~{R},7~{S},8~{R},9~{S},12~{S},13~{R},16~{S})-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-18-ene-6,2'-oxane]-16-yl]oxyethyl]propane-1,3-diol(Non-covalent)
DU0.13: 19 residues within 4Å:- Chain A: L.1011, P.1027, S.1028, W.1029, L.1031, A.1032, I.1035
- Chain D: L.863, L.866, M.867, T.870, F.871, L.874, Y.972, L.975
- Ligands: POV.6, POV.12, POV.51, POV.52
10 PLIP interactions:5 interactions with chain D, 5 interactions with chain A- Hydrophobic interactions: D:M.867, D:T.870, D:F.871, D:F.871, D:Y.972, A:W.1029, A:W.1029, A:L.1031, A:I.1035
- Hydrogen bonds: A:P.1027
DU0.17: 19 residues within 4Å:- Chain A: L.863, L.866, M.867, T.870, F.871, L.874, Y.972, L.975
- Chain B: L.1011, P.1027, S.1028, W.1029, L.1031, A.1032, I.1035
- Ligands: POV.15, POV.16, POV.31, POV.36
9 PLIP interactions:4 interactions with chain B, 5 interactions with chain A- Hydrophobic interactions: B:W.1029, B:L.1031, B:I.1035, A:M.867, A:T.870, A:F.871, A:F.871, A:Y.972
- Hydrogen bonds: B:P.1027
DU0.35: 19 residues within 4Å:- Chain B: L.863, L.866, M.867, T.870, F.871, L.874, Y.972, L.975
- Chain C: L.1011, P.1027, S.1028, W.1029, L.1031, A.1032, I.1035
- Ligands: POV.33, POV.34, POV.41, POV.47
9 PLIP interactions:5 interactions with chain B, 4 interactions with chain C- Hydrophobic interactions: B:M.867, B:T.870, B:F.871, B:F.871, B:Y.972, C:W.1029, C:L.1031, C:I.1035
- Hydrogen bonds: C:P.1027
DU0.64: 19 residues within 4Å:- Chain C: L.863, L.866, M.867, T.870, F.871, L.874, Y.972, L.975
- Chain D: L.1011, P.1027, S.1028, W.1029, L.1031, A.1032, I.1035
- Ligands: POV.19, POV.49, POV.50, POV.63
9 PLIP interactions:4 interactions with chain D, 5 interactions with chain C- Hydrophobic interactions: D:W.1029, D:L.1031, D:I.1035, C:M.867, C:T.870, C:F.871, C:F.871, C:Y.972
- Hydrogen bonds: D:P.1027
- 4 x ZY8: (4bS,8R,8aS,14bR)-7-(cyclopropylmethyl)-5,6,7,8,9,14b-hexahydro-8aH-4,8-methanobis[1]benzofuro[3,2-e:2',3'-g]isoquinoline-1,8a-diol(Non-covalent)
ZY8.14: 15 residues within 4Å:- Chain A: M.705, M.740, S.743, D.744, M.747, N.751, M.752, R.753, S.756, K.776, H.783
- Chain B: D.669, L.670, V.671, D.672
8 PLIP interactions:4 interactions with chain A, 4 interactions with chain B- Hydrophobic interactions: A:R.753, B:L.670, B:L.670
- Water bridges: A:S.743, B:V.671
- Salt bridges: A:D.744
- pi-Cation interactions: A:K.776
- Hydrogen bonds: B:D.672
ZY8.32: 14 residues within 4Å:- Chain B: M.705, M.740, S.743, D.744, M.747, N.751, M.752, R.753, K.776, H.783
- Chain C: D.669, L.670, V.671, D.672
8 PLIP interactions:4 interactions with chain C, 4 interactions with chain B- Hydrophobic interactions: C:L.670, C:L.670, B:R.753
- Hydrogen bonds: C:D.672
- Water bridges: C:V.671, B:S.743
- Salt bridges: B:D.744
- pi-Cation interactions: B:K.776
ZY8.48: 15 residues within 4Å:- Chain C: M.705, M.740, S.743, D.744, M.747, N.751, M.752, R.753, S.756, K.776, H.783
- Chain D: D.669, L.670, V.671, D.672
8 PLIP interactions:4 interactions with chain C, 4 interactions with chain D- Hydrophobic interactions: C:R.753, D:L.670, D:L.670
- Water bridges: C:S.743, D:V.671
- Salt bridges: C:D.744
- pi-Cation interactions: C:K.776
- Hydrogen bonds: D:D.672
ZY8.65: 15 residues within 4Å:- Chain A: D.669, L.670, V.671, D.672
- Chain D: M.705, M.740, S.743, D.744, M.747, N.751, M.752, R.753, S.756, K.776, H.783
8 PLIP interactions:4 interactions with chain A, 4 interactions with chain D- Hydrophobic interactions: A:L.670, A:L.670, D:R.753
- Hydrogen bonds: A:D.672
- Water bridges: A:V.671, D:S.743
- Salt bridges: D:D.744
- pi-Cation interactions: D:K.776
- 1 x CA: CALCIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nadezhdin, K.D. et al., Structural mechanisms of TRPM7 activation and inhibition. Nat Commun (2023)
- Release Date
- 2023-05-17
- Peptides
- Transient receptor potential cation channel subfamily M member 7: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 52 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
- 4 x DU0: 2-[2-[(1~{S},2~{S},4~{S},5'~{R},6~{R},7~{S},8~{R},9~{S},12~{S},13~{R},16~{S})-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-18-ene-6,2'-oxane]-16-yl]oxyethyl]propane-1,3-diol(Non-covalent)
- 4 x ZY8: (4bS,8R,8aS,14bR)-7-(cyclopropylmethyl)-5,6,7,8,9,14b-hexahydro-8aH-4,8-methanobis[1]benzofuro[3,2-e:2',3'-g]isoquinoline-1,8a-diol(Non-covalent)
- 1 x CA: CALCIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nadezhdin, K.D. et al., Structural mechanisms of TRPM7 activation and inhibition. Nat Commun (2023)
- Release Date
- 2023-05-17
- Peptides
- Transient receptor potential cation channel subfamily M member 7: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.